SCHEMBL3452725

SCHEMBL3452725

CC[C@H]1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2CCC3=CC(=O)CC[C@@H]3[C@@H]12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SERPINA6 P08185 4/20 0.61
▸ SHBG P04278 3/20 0.61
▸ SLC22A1 O15245 1/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ THRB P10828 1/20 0.61
▸ AR P10275 5/20 0.50
▸ PGR P06401 4/20 0.48
▸ NR3C1 P04150 4/20 0.47
▸ LMNA P02545 4/20 0.46
▸ MAPT P10636 2/20 0.46
▸ PDK1 Q15118 2/20 0.43
▸ PDK2 Q15119 2/20 0.43
▸ PDK3 Q15120 2/20 0.43
▸ PDK4 Q16654 2/20 0.43
▸ CYP19A1 P11511 5/20 0.43
▸ HSD17B10 Q99714 3/20 0.42
▸ CYP3A4 P08684 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ SNCA P37840 2/20 0.42
▸ CACNA1C Q13936 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8808857 0.89 SERPINA6 (0.57) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL6241504 0.86 SERPINA6 (0.67) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL7891295 0.85 SERPINA6 (0.47) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL7703094 0.85 SERPINA6 (0.47) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL7703091 0.85 SERPINA6 (0.47) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL24102505 0.85 SERPINA6 (0.65) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL24102420 0.85 SERPINA6 (0.65) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL21405873 0.85 SERPINA6 (0.65) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL3452660 0.85 SERPINA6 (0.65) SERPINA6SHBGSLC22A1ALDH1A1THRB
SCHEMBL24102619 0.85 SERPINA6 (0.65) SERPINA6SHBGSLC22A1ALDH1A1THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820642-B2 Nandrolone 17β-carbonates THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2010-10-26 — — US disclosed
EP-1846434-B1 NANDROLONE 17ß-CARBONATES US GOV HEALTH & HUMAN SERV (US) 2009-03-25 — — EP disclosed
US-20080167283-A1 Nandrolone 17 Beta-Carbonates GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRE- SENTED BY THE SECRETARY, DEPA (US) 2008-07-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080167283-A1 Nandrolone 17 Beta-Carbonates HSD3B1, HSD3B2, HSD17B7 SERPINA6 369/4885SHBG 22/4885SLC22A1 706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback